Emerging Cell Therapies: Realizing the Vision of NextGen Cell Therapeutics | EK15

Jan 25, 2021 ‐ Jan 27, 2021



Sessions

Myeloid Cell Contribution to Tumor Lesion Composition and Outcome

Jan 27, 2021 5:00pm ‐ Jan 27, 2021 5:25pm

Speaker(s):

Immune Cell Biology: Implications for Cellular Immunotherapy

Jan 27, 2021 5:00pm ‐ Jan 27, 2021 8:00pm

Co-Chair(s):

Regulation of T Cell Function in Tumors

Jan 27, 2021 5:25pm ‐ Jan 27, 2021 5:50pm

Speaker(s):

NK Cells in Health and Disease iconNK Cells in Health and Disease

Preview Available

NK Cells in Health and Disease

Jan 27, 2021 5:50pm ‐ Jan 27, 2021 6:15pm

Speaker(s):

Coffee Break iconCoffee Break

Preview Available

Coffee Break

Jan 27, 2021 6:15pm ‐ Jan 27, 2021 6:45pm


Short Talk: Disrupting Enhancers within the Core Epigenetic Program of Exhaustion Improves CD8+ T Cell Responses and Enhances Tumor Control

Jan 27, 2021 6:45pm ‐ Jan 27, 2021 7:00pm

Speaker(s):

Short Talk: Mapping Cellular Interactions between Cancer and Normal Cells via Synthetic Notch Ligand/Receptor Pairs

Jan 27, 2021 7:00pm ‐ Jan 27, 2021 7:15pm

Speaker(s):

Short Talk: Unbiased Design of Engineered T Cell Therapies Using Functional CRISPR/Cas9 Screens

Jan 27, 2021 7:15pm ‐ Jan 27, 2021 7:30pm

Speaker(s):

Short Talk: Uncovering the Cell-Type Specificity in Human T1D Immune Activation Using iPSC-beta Cells

Jan 27, 2021 7:30pm ‐ Jan 27, 2021 7:45pm

Speaker(s):

Closing Remarks iconClosing Remarks

Preview Available

Closing Remarks

Jan 27, 2021 7:45pm ‐ Jan 27, 2021 8:00pm